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Abstract
Understanding respiratory syncytial virus (RSV) circulation patterns is necessary to 
guide the timing of limited-duration interventions such as vaccines. We describe RSV 
circulation over multiple seasons in three distinct counties of Kenya during 2006-
2018. Kilifi and Siaya counties each had consistent but distinct RSV seasonality, last-
ing on average 18-22 weeks. Based on data from available years, RSV did not have a 
clear pattern of circulation in Nairobi. This information can help guide the timing of 
vaccines and immunoprophylaxis products that are under development.
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1  | INTRODUC TION
Respiratory syncytial virus (RSV) is a leading cause of severe acute 
respiratory infections in children < 5 years of age worldwide, with 
most of the disease burden occurring in developing countries.1 RSV 
is estimated to cause 33.8 million cases of lower respiratory tract 
infections (LRTI) and at least 3.4 million hospitalizations globally.1 
Studies have demonstrated a significant burden of RSV in Kenya 
with an annual RSV hospitalization rate estimated at 5 per 1000 
among children < 5 years of age.2-6
Several RSV vaccines and immunoprophylaxis products target-
ing young infants are in development, and may be available within 
the next few years.7 However, the duration of protection of these 
products may be <6 months.8,9 Therefore, understanding regional 
RSV circulation is necessary to guide the timing of clinical trials and 
administration of products once licensed.
Data on RSV circulation patterns in Kenya are sparse, and previ-
ous studies have been limited to one or two regions.10,11 We describe 
RSV circulation over multiple seasons in three distinct counties of 
Kenya during 2006-2018.
2  | METHODS
All results of testing for RSV from the Kenya Medical Research 
Institute (KEMRI)-Wellcome Trust Research Programme, and 
KEMRI-Center for Global Health Research during the 13-year period 
from 2006-2018 were included in our analysis, regardless of labora-
tory testing methods, population tested, or the case definition used. 
Tested samples were collected from sites within three counties of 
Kenya: Kilifi, Nairobi, and Siaya (Figure 1).
In Kilifi, samples were collected from children aged 1 day to 
<5 years of age with syndromic severe or very severe pneumonia.12 
In Nairobi, respiratory specimens were collected from all ages with 
influenza-like illness (ILI) or acute lower respiratory illness (ALRI) at 
an outpatient clinic, Tabitha Clinic, and with severe acute respiratory 
illness (SARI) at an inpatient hospital, Kenyatta National Hospital. In 
Siaya, respiratory samples were collected from 3 inpatient hospitals 
and 3 outpatient clinics from patients of all ages with varying case 
definitions, including ILI, ALRI, SARI, and acute respiratory illness 
(ARI). See Table 1 for details of site testing populations, case defini-
tions, and dates of specimen collection.
We used the number of specimens tested and the number of RSV 
detections to describe the percent positive by week within each region. 
To describe the season, we took the 5-week moving average (previous 
2 weeks, current week, and two subsequent weeks) of the weekly per-
cent positive in each county, similar to previous approaches.11,13 We 
described whether a consistent season was observed, and if so, the 
onset, offset, and peak weeks within each county. We defined season 
onset as the first of three consecutive weeks during which the moving 
average percentage positive was greater than the mean of the 5-week 
moving average percentage positive for that calendar year. We defined 
the season offset as the third of three consecutive weeks following 
season onset by at least 5 weeks during which the moving average 
F I G U R E  1   Map of Kenya and 
surrounding countries, including the three 
counties with RSV tests during the study 
period
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percentage positive was below the average of the 5-week moving av-
erage percentage positive. The peak of the season was defined as the 
highest moving average percentage positive between the season onset 
and offset. We define the sensitivity of the season as the percentage of 
detections that occurred during each defined season, inclusive of the 
onset and offset.
3  | RESULTS
Overall between January 1, 2006, and December 31, 2018, 31 722 
RSV tests were collected from Kilifi, Nairobi, and Siaya counties. In 
Nairobi and Siaya, all tests were done by molecular methods. In Kilifi, 
either antigen or molecular methods were used. Overall, 4571 (14%) 
tests were positive for RSV (Table 1).
In Kilifi, all 9572 tests were collected at Kilifi County Hospital, of 
which 2477 (26%) were positive for RSV. In Nairobi, 5574 tests were 
collected, of which 687 (12%) were positive for RSV. In Siaya, 16 576 
tests were collected from six surveillance sites, of which 1407 (8%) 
were positive for RSV (Table 1).
Kilifi and Siaya each had consistent but distinct seasonality 
(Figure 2). Testing for RSV was discontinued in Nairobi from May 
2011 until August 2014. Based on available years, RSV did not have 
a clear pattern of circulation in Nairobi, and we could not define sea-
son onset, offset, or peak for that region (Figure 2, Table 1).
The season onset in Kilifi occurred between mid-October and 
early February each year, and season offset occurred between late 
March and mid-June. The average season duration was 22 weeks 
(range: 16-29 weeks). The peak occurred between late December 
and late April, and most commonly occurred in February. The de-
fined season captured 81%-97% of detections each year, and across 
all years, the median sensitivity of the season was 88% (Table 2).
Siaya season onset occurred between late February and mid-
June each year, and season offset occurred between mid-July and 
TA B L E  1   Summary of specimens tested for RSV by region







Kilifia  Kilifi County 
Hospital
Syndromic severe or very severe 
pneumoniab , 1 d to <5 y
1/06-12/18 Antigen 9572 2477 (26)
1/07-10/18 Molecular
Nairobi Kenyatta National 
Hospital
SARIc , all ages 8/14-3/16 Molecular 867 155 (18)
Tabitha Clinic ILId  or ALRIe , all ages 10/06-4/11 Molecular 4707 532 (11)
Siaya Bondo Sub-County 
Hospital and Siaya 
County Referral 
Hospital










ILId  or ALRIe , all ages 1/06-11/12 Molecular 4890 542 (11)
Siaya County 
Referral Hospital
SARIc , all ages 8/09-11/13 Molecular 5654 550 (10)
Siaya County 
Referral Hospital
SARIh , all ages 12/13-11/18 Molecular 2294 130 (6)
Total 31 722 4571 (14)
aSome specimens tested by antigen and multiple molecular methods. 
bSyndromic severe or very severe pneumonia: cough or difficulty in breathing for <30 d, with lower chest wall indrawing, prostration (including 
inability to feed or drink), coma, or hypoxemia (pO2 < 90%). 
cSevere acute respiratory infection (SARI): cough and reported fever or a recorded temperature of ≥38°C, with an onset within the last 14 d. 
dInfluenza-like illness (ILI): cough or sore throat with axillary temperature ≥ 38°C with an onset within the last 14 d. 
eAcute lower respiratory infection (ALRI): for ≥5 y of age: cough or difficulty breathing or chest pain, with axillary temperature ≥ 38.0°C, oxygen 
saturation level ≤ 90% and/or hospitalization, with onset within the last 14 d; For <5 y of age: cough or difficulty breathing, and at least one of 
indrawing, oxygen saturation level ≤90%, stridor, inability to feed or drink, vomiting everything, lethargy, unconscious, convulsions, or hospitalization. 
fAcute respiratory infection, pregnant women (ARI): cough or difficulty breathing within the past 10 d. 
gARI, infants: cough, difficulty breathing, runny nose or other respiratory illness within the past 10 d. 
hSARI: cough and reported fever or a recorded temperature of ≥38°C, with an onset within the last 10 d. 
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early September, except for the 2009 season which had an atypical 
offset in January. We could not adequately describe the 2006 sea-
son in Siaya due to low number of tests (N = 168). The average sea-
son duration was 18 weeks (range: 14-23 weeks). The peak occurred 
between mid-May and early July, except the 2009 season during 
which the peak occurred in September. Most commonly, the peak of 
the season occurred in June. The defined season captured 63%-99% 
of detections each year, and across all years, the median sensitivity 
of the season was 80%.
4  | DISCUSSION
The observed circulation patterns of RSV differed between regions 
of Kenya. In the two regions where RSV season could be defined, 
there was little overlap, with the peak generally occurring in Kilifi 
(Eastern coastal Kenya) between late December and late April and 
in Siaya (Western Kenya) between mid-May and early July. With 
available data, the season could not be defined in the Nairobi re-
gion. These data may be used to make evidence-based decisions 
F I G U R E  2   The number of specimens that were tested for RSV (bars) and the 5-mo moving average percentage that were positive (black 
line) by week and county. In regions with a distinct season (Kilifi and Siaya), each season is shown in blue (inclusive of onset and offset), and 
each season peak is indicated by a red star. A. Kilifi, B. Siaya, C. Nairobi
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in Kenya about optimal timing of vaccine and immunoprophylaxis 
products that may be licensed in the near future, as these prod-
ucts will provide limited duration of protection. Appropriately 
timing implementation of products with limited duration could be 
challenging in regions with varying and inconsistent patterns of 
circulation.
Our findings in Kilifi are consistent with previous studies, which 
also found the peak occurred on average in February during 2002-
2006.10,12 Previous studies found distinct, but inconsistent seasons 
in Nairobi,10,11,14 but these analyses, like ours, were limited to only a 
few years. It is possible that additional data over longer continuous 
periods of time would reveal a specific RSV seasonality in the region. 
Previous studies did not find distinct seasons in Siaya during 2007-
2010, but our analysis over a longer period of time generally showed 
a distinct and consistent season in this county, with the exception 
of 2009.11,15 The atypical findings from that year may have been the 
result of the influenza A/H1N1pdm09 pandemic's effect on testing 
and circulation of other viruses.3,11
In tropical climates, some studies showed that RSV circulation 
patterns may be less defined, although other studies found tropi-
cal regions to have predictable circulation patterns.10 Despite both 
having tropical climates and rural settings, two of the three counties 
studied had consistent RSV seasons that were distinct from each 
other. There was wide variation in season onset and offset making 
seasons somewhat variable, but still a distinct season can be recog-
nized. In Kilifi, >80% of detections each year were captured by the 
defined season. In Siaya, >62% of detections each year and >90% 
of detections in the last 3 years of this analysis were captured each 
season. In addition to understanding the duration of the season, rec-
ognizing peaks in infections is important to maximize the number of 
cases prevented when interventions are of limited duration. Several 
additional factors may influence the observed RSV seasonality, in-
cluding access to healthcare, social and behavior characteristics, and 
susceptibility to infection.
Our study has several limitations. First, we compiled all available 
laboratory-confirmed RSV tests in the three regions of our study, 
but testing practices, case definitions, age ranges, and methods 
varied by site and year. These differences may impact the sensi-
tivity and specificity of RSV detections and the season duration. 
However, we believe that by comparing the percentage of positive 
tests relative to other points in time, we likely captured overall 
circulation patterns. This approach has also been used in previous 
studies.13 Second, data from Nairobi were limited, and with more 
data, a distinctive pattern may emerge. Third, we did not include any 
demographic information or information on clinical severity. We can 
only assume that the observed patterns held true across age groups 
and that interventions covering the defined seasons would prevent 
the most severe cases.
Understanding RSV seasonality is important to provide recom-
mendations for optimal timing of interventions against RSV infec-
tion, particularly ones that may offer protection for a few months. 
This is particularly true for low- and middle-income countries where 
competing priorities make optimizing resources essential. More 
studies on a regional level in low- and middle-income countries are 
important to understand RSV patterns of circulation prior the licen-
sure of products that are currently in development.
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